Immune

Derived and engineered immune cells, including T cells and NK cells, present exciting potential for use in cancer immunotherapies. Generation of functional T cells from hPSCs allows for potential off-the-shelf T cell therapies, while genetically engineered CAR T cells enable targeted immunotherapy treatments.

Explore our portfolio of products to support your T cell and NK cell workflows.